NCT05895734 (EMPOW) is a NA clinical trial of NDS-Powerball®, in Neurologic Disorder, sponsored by Universidad Rey Juan Carlos.

Who is sponsoring NCT05895734?

NCT05895734 is sponsored by Universidad Rey Juan Carlos.

What drugs are being tested in NCT05895734?

Interventions in NCT05895734: NDS-Powerball®,, Conventional treatment.

What condition does NCT05895734 study?

NCT05895734 studies Neurologic Disorder, Multiple Sclerosis.

Is NCT05895734 still recruiting?

NCT05895734 is currently completed. Last updated 14 July 2023.

Last reviewed 2023-07-14 · How we verify

NCT05895734: EMPOW

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Powerball System in People With Multiple Sclerosis

Completed NA Last updated 14 July 2023

What this trial tests

NA trial testing NDS-Powerball®, in Neurologic Disorder in 25 participants. Completed in 10 July 2023.

Timeline

10 January 2023

Primary endpoint
10 July 2023

10 July 2023

Quick facts

Lead sponsor	Universidad Rey Juan Carlos
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	25
Start date	10 January 2023
Primary completion	10 July 2023
Estimated completion	10 July 2023
Sites	1 location across Spain

Drugs / interventions tested

NDS-Powerball®,
Conventional treatment — full drug profile →

Conditions studied

Neurologic Disorder — all drugs for Neurologic Disorder →
Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Universidad Rey Juan Carlos — full company profile →

Who can join

Adults 20 to 60, any sex, with Neurologic Disorder or Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is a high percentage of impairment in the upper limbs (UL) in patients with multiple sclerosis (MS), being muscle strength and hand dexterity a determining factor for the preservation of functional activities, constituting the basis of independence and quality of life. The aim of this study is to determine the effects of a training protocol on UL muscle strength, through the NDS-Powerball® system, in combination with conventional physiotherapy, during 8 weeks in terms of muscle strength, coordination, fatigue, functionality and quality of life in people with MS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Neurologic Disorder

Currently open trials in the same condition.

NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT06208332 — The "What Is Important to Us" Communication Intervention Pilot Clinical Trial · Phase 2 · recruiting
NCT06750692 — Comparison of the Effects of Mirror Therapy,rTMS and Robotic-assisted Hand Therapy in Stroke Patients · NA · recruiting
NCT06883227 — Investigating Health Impacts of Exposure to Harmful Algal Blooms · recruiting
NCT06523270 — Advanced Imaging Holistic Omics Biobank · recruiting

Other Universidad Rey Juan Carlos trials

Trials by the same sponsor.

NCT07524400 — Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease · NA · recruiting
NCT07402902 — Caffeine Strategies and Fat Oxidation · NA · not yet recruiting
NCT07251738 — Understanding the Lived Experience and Bereavement of Caregivers of People With Alzheimer's Disease · not yet recruiting
NCT07247760 — PATIENT SATISFACTION AND MASKING OF WHITE SPOT LESIONS AFTER HOME WHITENING WITH 10% CARBAMIDE PEROXIDE · NA · enrolling by invitation
NCT06968676 — Mixed Reality for Upper Limb Rehabilitation in People With Multiple Sclerosis (VIRTUALDOMUS) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05895734 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Rey Juan Carlos
Last refreshed: 14 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05895734.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing